-
FDA utökar användningsområdet för Ozempic
FDA har godkänt Ozempic som den första GLP-1-analogen att minska risken för försämrad njursjukdom.
-
Sahlgrenska Science Park och UC Berkeley ingår partnerskap – ska hjälpa deeptech-bolag
Sahlgrenska Science Parks accelerator Co-Ax har ingått ett samarbete med UC Berkeleys innovationslabb för deeptech. Syftet med partnerskapet är att accelerera tillväxten av deeptech-bolag i Sverige och Norden.
-
Innovative start-up helps doctors, scientists and industry balance coagulation risks
For many doctors caring for seriously ill patients, for example, in stroke units and cancer wards, maintaining the life-saving balance between bleeding and thrombosis is an ongoing challenge. In the late 1980s, scientists at Maastricht University in the Netherlands developed an innovative method, the thrombin generation assay (TGA), which provides a complete overview of a physiological process crucial for maintaining normal haemostasis.
-
Suing the company – for NOT developing a new HIV drug
Was Gilead putting a steady flow of profits from its cash cow ahead of developing a new and safer drug? According to a large number of US HIV patients in a legal case with an unusual twist, the answer is yes.
-
Column: ”Cheating with pea flowers and does it matter whether you are right?”
Is it possible to forgive shortcuts or outright cheating in science - if it turns out that the researcher was ultimately right? Anna Törner discuss this topic in a column.
-
“We need to build flexible operating theatres”
Flexible operating theatres, micro-sensors on surgeons to monitor their well-being and 3D images projected onto organs to be operated on. These are a few ideas that three specialist surgeons are suggesting for the operating theatre of the future.
-
Hello Angelica Loskog!
Life Science Sweden would like to know more about Angelica Loskog and interviews her about her life as a researcher.
-
Lucy Robertshaw: There is a bio revolution happening right now
Lucy Robertshaw is both proud and excited to be taking the baton of moderating this year’s Pharma Outsourcing event.
-
Fortsätter med strategin
Karolinska Development visar upp fortsatta förluster under det fjärde kvartalet men räknar med minskade kostnader framöver.
-
KD i nytt avtal
Karolinska Development tecknar deal flow-avtal med Karolinska Institutet.
-
Proteintrend banar väg för nytt företag
Grundarna till nystartade CRO-bolaget Solve Research and Consultancy fick sin affärsidé när fler och fler företag visade intresse för deras analysmetod Field-flow fractionation.
-
Biopharma banar väg för nytt analysföretag
Grundarna till nystartade CRO-bolaget Solve Research and Consultancy fick sin affärsidé när fler och fler företag visade intresse för deras analysmetod Field-flow fractionation.
-
How to get visitors to your booth
Food, ball throwing and laser engraved pens. There are many tricks to attract visitors to the stands at Scanlab.
-
Alan Hulme till KD-bolag
Karolinska Development-bolaget Oncopeptides nya styrelseordförande har 30 års erfarenhet från life science-branschen.
-
Many rotor options for refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
Platform for high security virus purification
Millipore Corporation has introduced the Viresolve Pro Solution system, a new system for purification of viruses. The technology in the new platform includes a novel patent pending membrane.
-
Multiple rotor options in refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
Få tillgång till allt innehåll på Life Science Sweden
Ingen bindningstid eller kortinformation krävs
Redan prenumerant? Logga in
Gäller endast personlig prenumeration.
Kontakta oss för en företagslösning.
BREAKING